A newly developed PAD2 inhibitor, AFM41a promoted M2 macrophage polarization and autophagy in Pseudomonas aeruginosa (PA)-induced sepsis model, offering promising avenues for the treatment of PA infection and the improvement of sepsis outcomes [122]. This evidence concerns the gene PADI2 and Sepsis.